Lv3
212 积分 2024-05-19 加入
The relationship between the gut microbiota and thyroid disorders
1天前
已完结
Gut microbiome and immune checkpoint inhibitor toxicity
2天前
已完结
Tertiary lymphoid structures in cancer
22天前
已完结
Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
2个月前
已完结
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
3个月前
已完结
MA09.03 Plasma Proteomics-based Models for Predicting Immunotherapy- and Chemotherapy-Related Toxicity in NSCLC Patients
3个月前
已关闭
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
3个月前
已完结
Association between programmed death protein 1-related single-nucleotide polymorphisms and immune-related adverse events induced by programmed death protein 1 inhibitors—a pilot study
3个月前
已完结
Distinct Cytokine Signatures in Thyroiditis Induced by PD-1 or CTLA-4 Blockade: Insights from a New Mouse Model
3个月前
已关闭
Providing Clarity Regarding the Mechanism for Immune Checkpoint Inhibitor–Associated Thyroiditis
3个月前
已完结
急性脑梗死患者血浆Lp-PLA2和hs-CRP水平及意义
7个月前
已采纳
皖公网安备34019202002308
